Back to RecallTracker
Health Canada Health products

Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosis

Issued June 22, 2015
Issue
Hazard description
Product safety
What to do
Symptoms of ketoacidosis include difficulty breathing, feeling very thirsty, vomiting, abdominal pain, nausea, loss of appetite, confusion, and unusual tiredness. Seek urgent medical attention if you think you have these symptoms. You should not stop treatment with Forxiga or Invokana without first consulting a healthcare professional. Talk to your doctor or pharmacist if you have any concerns about your diabetic treatment.